Centrum 7/6  banner

generic version of Namenda

Upsher-Smith gains approval for Namenda generic

MAPLE GROVE, Minn. — Upsher-Smith Laboratories Inc. has received approval from the Food and Drug Administration of an Abbreviated New Drug Application (ANDA) for memantine hydrochloride tablets, a treatment for Alzheimer’s disease, in strengths of 5 mg and 10 mg. Upsher-Smith said Monday that its product is a generic version of Namenda from Forest Laboratories,